脓毒症免疫失衡机制及中医治疗
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

北京市医院管理局重点医学专业发展计划专项(ZYLX201611);国家自然科学基金委员会资助项目(81673934)


Mechanism of Immunologic Dissonance in Sepsis and the Progress of Traditional Chinese Treatment
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    脓毒症高致死率使其成为人类健康的重大威胁,其发病机制尚未完全明确,已知免疫失衡是其主要发病机制之一。高迁移率族蛋白B1(High Mobility Group Box1 Protein,HMGB1)是致免疫失衡的关键因子,有RAGE、TLRs和CD24等多种受体,可通过与受体结合,介导多种信号转导通路,从而发挥免疫调节功能。中药以单体和复方治疗脓毒症均取得一定进展,有待进一步结合现代医学共同应对脓毒症挑战。

    Abstract:

    The high fatality rate of sepsis has become a major threat to human health, and its pathogenesis has not been fully defined. Now we know immunologic dissonance is one of the main pathogenesis of sepsis. HMGB1 is a key factor for the immune imbalance. There are many kinds of receptors, such as RAGE, TLRs and CD24, which can mediate various signal transduction pathways by binding to the receptors, thus giving play to the immunomodulation function. The treatment of sepsis by traditional Chinese medicine single and compound has made some progress, and it remains to be further combined with modern medicine to cope with the challenges of sepsis.

    参考文献
    相似文献
    引证文献
引用本文

卢幼然,狄浩然,丁军颖,郭玉红,刘清泉.脓毒症免疫失衡机制及中医治疗[J].世界中医药,2018,(09).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2017-07-20
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-10-16
  • 出版日期:
文章二维码